The team is also working on prevention of related Ebolavirus members Sudan virus (SUDV) and Bundibugyo virus (BDBV), and
the related filovirus Marburg virus.
«Our results provide a roadmap to developing a single antibody - based treatment effective against not only infections caused by Ebola Zaire virus, but also caused by
related filoviruses.»
The question is, can these antibodies protect against a future infection with the virus and
related filoviruses?